Close Menu

No Competing Here

Aled Edwards, the CEO of the Structural Genomics Consortium, tells the Globe and Mail that it makes no sense for pharmaceutical scientists at different organizations to be working on the same problems. "The semiconductor industry in the '80s started to collaborate with one another on the platform," Edwards says. "They said: Every one of us generating a unique platform on which to build our hardware is silly, right?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.